Global Interventional Cardiology Peripheral Vascular Devices Market
Marktgröße in Milliarden USD
CAGR :
% 
 Prognosezeitraum |
2024 –2031 |
 Marktgröße (Basisjahr) | USD 20.03 Billion |
 Marktgröße (Prognosejahr) | USD 35.72 Billion |
 CAGR |
% |
| Wichtige Marktteilnehmer |
|
Global Interventional Cardiology and Peripheral Vascular Devices Market Segmentation, By Product (Angioplasty Balloons, Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Accessories and Hemodynamic Flow Alteration Devices), Type (Conventional and Standard), Procedure (Iliac Intervention, Femoropopliteal Interventions, Tibial (Below-The-Knee) Interventions, Peripheral Angioplasty, Arterial Thrombectomy and Peripheral Atherectomy), Indication (Peripheral Arterial Disease And Coronary Intervention), Age Group (Geriatric, Adults and Pediatric), End User (Hospitals, Ambulatory Surgery Centers, Nursing Facilities, Clinics and Others), Distribution Channel (Direct Tender, Third Party Distributors and Others) – Industry Trends and Forecast to 2031.
Interventional Cardiology and Peripheral Vascular Devices Market Analysis
Cardiology include a branch of drugs that deal with various disorders of the guts, along with circularity system. The cardiology field treats heart failure and several other diseases that plague heart patients. The growth in the geriatric population is escalating the growth of interventional cardiology and peripheral vascular devices market.
Interventional Cardiology and Peripheral Vascular Devices Market Size
Global interventional cardiology and peripheral vascular devices market size was valued at USD 20.03 billion in 2023 and is projected to reach USD 35.72 billion by 2031, with a CAGR of 7.5% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes |
Interventional Cardiology and Peripheral Vascular Devices Key Market Insights |
|
Segmentation |
|
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Key Market Players |
Medtronic (Ireland), BD. (US), Cordis. (US), Abbott. (US), Boston Scientific Corporation (US), Cook (UK), Cardiovascular Systems, Inc. (US), AngioDynamics. (US), Edwards Lifesciences Corporation. (US), Biosensors International Group, Ltd. (Singapore), W. L. Gore & Associates, Inc. (US), Teleflex Incorporated. (US), OrbusNeich Medical Company Limited (Hong Kong), Merit Medical Systems. (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (Germany), MicroPort Scientific Corporation (China), Lepu Medical Technology(Beijing)Co.,Ltd (China), and Koninklijke Philips N.V. (Netherlands), among others |
Interventional Cardiology and Peripheral Vascular Devices Market Definition
Interventional cardiology with catheter-based technologies for treating structural heart diseases. The procedure consists of inserting a device, such as balloon, catheter, stent, or other devices into the femoral artery. Numerous interventional devices are widely deployed for treating peripheral vascular disorders that affect the circulatory system.
Interventional Cardiology and Peripheral Vascular Devices Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Geriatric Population
The increase in the geriatric population acts as one of the major factors driving the growth of interventional cardiology and peripheral vascular devices market as the ageing population is more prone to diseases.
- Favorable Reimbursement
The presence of favorable reimbursement scenario for peripheral vascular procedures accelerate the market growth.
- Cardiovascular Conditions
The use of the interventional cardiology and peripheral vascular devices for treating numerous cardiovascular conditions through catheters and minimal invasion further influence the market.
Opportunities
Furthermore, increase in the preference for minimally invasive cardiac procedures owing to the advantages, including less invasion, blood loss and pain extend profitable opportunities to the market players in the forecast period of 2022 to 2029.
Restraints/Challenges
On the other hand, increased number of product failures and recalls are expected to obstruct market growth. Also, rise in the availability of alternative treatments and dearth of skilled professionals with expertise in peripheral vascular devices are projected to challenge the interventional cardiology and peripheral vascular devices market in the forecast period of 2024-2031.
This interventional cardiology and peripheral vascular devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on interventional cardiology and peripheral vascular devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Interventional Cardiology and Peripheral Vascular Devices Market
COVID-19 outbreak had varied impact on interventional cardiology and peripheral vascular devices market. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. Major medical procedures were declined during the pandemic in order to prevent the risk of spreading coronavirus. However, rise in the interventional cardiology procedures is expected in the post-COVID owing to the easing of restrictions.
Interventional Cardiology and Peripheral Vascular Devices Market Scope
The interventional cardiology and peripheral vascular devices market is segmented on the basis of product, type, procedure, indication, age group, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Angioplasty Balloons
- Stent
- Catheters
- Endovascular Aneurysm Repair Stent Grafts
- Inferior Vena Cava (IVC) Filters
- Plaque Modification Devices
- Accessories and Hemodynamic Flow Alteration Devices
On the basis of product, the global interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, accessories and hemodynamic flow alteration devices.
Type
- Conventional
- Standard
On the basis of type, the global interventional cardiology and peripheral vascular devices market is segmented into conventional and standard.
Procedure
- Iliac Intervention
- Femoropopliteal Interventions
- Tibial (Below-The-Knee) Interventions
- Peripheral Angioplasty
- Arterial Thrombectomy
- Peripheral Atherectomy
On the basis of procedure, the global interventional cardiology and peripheral vascular devices market is segmented into iliac intervention, femoropopliteal interventions, tibial (below-the-knee) interventions, peripheral angioplasty, arterial thrombectomy and peripheral atherectomy.
Indication
- Peripheral Arterial Disease
- Coronary Intervention
On the basis of indication, the global interventional cardiology and peripheral vascular devices market is segmented into peripheral arterial disease and coronary intervention.
Age Group
- Geriatric
- Adults
- Paediatric
On the basis of age group, the global interventional cardiology and peripheral vascular devices market is segmented into geriatric, adults and paediatric.
End User
- Hospitals
- Ambulatory Surgery Centers
- Nursing Facilities
- Clinics
- Others
On the basis of end user, the global interventional cardiology and peripheral vascular devices market is segmented into hospitals, ambulatory surgery centers, nursing facilities, clinics and others.
Interventional Cardiology and Peripheral Vascular Devices Market Regional Analysis
The interventional cardiology and peripheral vascular devices market is analysed and market size insights and trends are provided by country, product, type, procedure, indication, age group, end user and distribution channel as referenced above.
The countries covered in the interventional cardiology and peripheral vascular devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the interventional cardiology and peripheral vascular devices market because of the growth in the geriatric population and the high prevalence of peripheral vascular diseases within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in the number of product approvals in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The interventional cardiology and peripheral vascular devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for interventional cardiology and peripheral vascular devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the interventional cardiology and peripheral vascular devices market. The data is available for historic period 2010-2020.
Interventional Cardiology and Peripheral Vascular Devices Market Share
The interventional cardiology and peripheral vascular devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to interventional cardiology and peripheral vascular devices market.
Interventional Cardiology and Peripheral Vascular Devices Market Leaders Operating in the Market Are:
- Medtronic (Ireland)
- BD. (US)
- Cordis. (US)
- Abbott. (US)
- Boston Scientific Corporation (US)
- Cook (UK)
- Cardiovascular Systems, Inc. (US)
- AngioDynamics. (US)
- Edwards Lifesciences Corporation. (US)
- Biosensors International Group, Ltd. (Singapore)
- W. L. Gore & Associates, Inc. (US)
- Teleflex Incorporated. (US)
- OrbusNeich Medical Company Limited (Hong Kong)
- Merit Medical Systems. (US)
- Terumo Medical Corporation (Japan)
- B. Braun Melsungen AG (Germany)
- MicroPort Scientific Corporation (China)
- Lepu Medical Technology(Beijing)Co.,Ltd (China)
- Koninklijke Philips N.V. (Netherlands)
Latest Development in Interventional Cardiology and Peripheral Vascular Devices Market
- Medtronic announced the approval of Freezor™ and Freezor™ Xtra Cardiac Cryoablation Focal Catheters by U.S. Food and Drug Administration (FDA) in February’2022. These are the first and only ablation catheters approved for treating pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).
SKU-
Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud
- Interaktives Datenanalyse-Dashboard
- Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
- Zugriff für Research-Analysten für Anpassungen und Abfragen
- Konkurrenzanalyse mit interaktivem Dashboard
- Aktuelle Nachrichten, Updates und Trendanalyse
- Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Forschungsmethodik
Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.
Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.
Anpassung möglich
Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.
